Pluripotency-associated gene regulatory elements

Pluripotency-associated gene regulatory elements are specialized genomic regions, including enhancers and promoters, that govern the expression of core transcription factors such as OCT4, SOX2, and NANOG (Boyer et al., 2005, Cell). These elements are fundamental to maintaining the self-renewal and undifferentiated state of embryonic stem cells and induced pluripotent stem cells (Young, 2011, Cell). Many of these regions are classified as "super-enhancers" due to their high density of transcription factor binding and enrichment of H3K27ac histone modifications (Whyte et al., 2013, Cell). In the context of disease, these regulatory elements can be aberrantly activated or hijacked by cancer cells to promote a "stemness" phenotype, leading to tumor progression and drug resistance (Hnisz et al., 2013, Cell). Although they are not traditional protein targets like receptors or enzymes, they represent a critical node for therapeutic intervention via epigenetic modulation (Sur and Taipale, 2016, Nature Reviews Genetics). Small molecules such as BET bromodomain inhibitors can disrupt the assembly of transcriptional complexes at these sites, thereby silencing pluripotency networks in cancer (Lovén et al., 2013, Cell). Additionally, CRISPR-based epigenome editing tools are being developed to precisely target these elements for gene silencing or activation in regenerative medicine and oncology (Padel et al., 2017, Nature Methods). The therapeutic challenge lies in the potential for off-target effects and the risk of inducing unintended cellular transformations or loss of normal tissue identity. Monitoring these elements often involves chromatin immunoprecipitation sequencing (ChIP-seq) to track the occupancy of master regulators and specific histone marks.

Other names

Pluripotency enhancersPluripotency-associated cis-regulatory elementsStem cell super-enhancersPluripotency gene promotersPluripotency-associated regulatory elements

Disruption of transcriptional co-activator recruitment and chromatin remodeling at pluripotency-associated loci.